Methyldopa and Enalapril Interaction
Drug interaction information between Methyldopa and Enalapril.
Methyldopa and Enalapril have a documented minor interaction in FDA labeling.
FDA drug labeling documents a minor-severity interaction between Methyldopa and Enalapril. Major interactions are generally avoided, moderate ones may need monitoring or a dose adjustment, and minor ones are usually low-risk. This page shows the documented mechanism and guidance. Label-documented interactions are not a complete safety review, so always confirm your own medications with a pharmacist or doctor. Educational information, not medical advice.
How They Interact
These medications work in different ways to lower blood pressure and have been used together without causing significant safety issues.
What To Do
This combination is generally safe, though your healthcare provider should continue to track your blood pressure regularly.
FDA Label Information
Other Cardiovascular Agents Enalapril maleate has been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions.
Methyldopa Also Interacts With
- Ferrous Sulfate moderate
- Carbidopa/Levodopa moderate
- Tranylcypromine moderate
- Lithium minor
- Colestipol minor
Enalapril Also Interacts With
- Aliskiren major
- Spironolactone minor
- Hydralazine minor
- Lithium minor
- Prazosin minor
Frequently Asked Questions
Can I take Methyldopa and Enalapril together?
This is a minor interaction. This combination is generally safe, though your healthcare provider should continue to track your blood pressure regularly.
How serious is the interaction between Methyldopa and Enalapril?
This interaction is classified as "minor" severity by the FDA. Minor interactions are unlikely to cause significant problems but should still be mentioned to your healthcare provider.
Why do Methyldopa and Enalapril interact?
These medications work in different ways to lower blood pressure and have been used together without causing significant safety issues.
Understanding the Methyldopa and Enalapril Interaction
FDA-approved prescribing information for these two drugs flags their combination as a minor-severity interaction. Methyldopa belongs to the Central Alpha-2 Agonist class and Enalapril belongs to the ACE Inhibitor class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: These medications work in different ways to lower blood pressure and have been used together without causing significant safety issues. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.
Context around a specific patient determines real-world impact. Methyldopa has 7 total documented interactions on file in this dataset, and Enalapril has 16. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: This combination is generally safe, though your healthcare provider should continue to track your blood pressure regularly. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.
An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Methyldopa or Enalapril based on a web page, speak with your prescriber or pharmacist before making any change.
Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. Always consult your healthcare provider about drug interactions.
Read our methodology - how this data is sourced, computed, and verified.